ResMed Announces Record Financial Results for the Quarter and Nine Months Ended June 30, 2013

San Diego – ResMed Inc. (NYSE: RMD)  announced record revenue and income for the quarter ended June 30, 2013. Revenue for the quarter ended June 30, 2013 was $414.6 million, an 11% increase (also an 11% increase on a constant currency basis) over the quarter ended June 30, 2012.  For the quarter ended June 30, 2013, GAAP income from operations was $86.2 million, while GAAP net income was $73.0 million or $0.50 per diluted share.  These results were impacted by a $24.8 million ($17.7 million, net of tax) charge for our previously announcedSydney University education, research and settlement expenses.  For the quarter ended June 30, 2013, non-GAAP operating income and non-GAAP net income were $110.9 million and $90.7 million, an increase of 24% and 18%, respectively, compared to the quarter ended June 30, 2012 (non-GAAP measures exclude the impact of the charge forSydney University education, research and settlement expenses, as described below).  Non-GAAP diluted earnings per share for the quarter ended June 30, 2013 were $0.62, an increase of 17% compared to the quarter ended June 30, 2012.

Source: ResMed News Website

The post ResMed Announces Record Financial Results for the Quarter and Nine Months Ended June 30, 2013 appeared first on Sleep Diagnosis and Therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA *